AIBTRUST develops and provides a medical information distribution platform utilizing Web 3.0 technology. The company offers the secure patient-controlled medical information management application MediReco and the DX system Health Interview, which facilitates the ethical utilization of clinical information by generative AI. AIBTRUST aims to promote the secure distribution and utilization of medical data, thereby contributing to the advancement of medical AI.
AIBTRUST株式会社（本社：大阪府大阪市北区、代表取締役：森岡 康一）は、本日2026年7月1日に京都市下京区に開院した「京都はぎわらクリニック」（院長：萩原 英恵）に対し、自社が提供する医療機関向けフルDXプ...
[画像: https://prtimes.jp/i/142041/8/resize/d142041-8-84e96744afebe5adfee5-1.png ] 電子カルテ導入だけでは進まない医療DXの本質的解決策として、AIBTRUST株式会社（本社：大阪市北区）は2026年6月、医療機...
[画像: https://prtimes.jp/i/142041/7/resize/d142041-7-7821e35f894f3d7378a6-0.png ] AIBTRUST株式会社（本社：大阪市北区、代表取締役：森岡 康一、以下「当社」）は、東京都が支援する日本発メドテック・ス...
[画像1: https://prtimes.jp/i/142041/5/resize/d142041-5-d82741db971a5e5767a4-1.png ] AIBTRUST株式会社（以下「AIBTRUST」）（本社：東京都港区、代表取締役：森岡康一）は、法人向けWeb3.0（ブロックチェー...
AIBTRUST株式会社（以下「AIBTRUST」）（本社：東京都港区、代表取締役：森岡康一）は、大阪大学ベンチャーキャピタル株式会社（以下「OUVC」）（本社：大阪府吹田市、代表取締役社長：清水速水）を無限責任組合...
[画像1: https://prtimes.jp/i/142041/2/resize/d142041-2-9532af4b76b555811bc7-0.png ] AIBTRUST株式会社（本社：東京都港区、代表取締役社長：森岡康一）は、医療機関が患者様に安全に医療情報を返却する事...
One of the challenges of the early detection of dementia is the lack of a simple screening method to detect cognitive impairment. A simple non-invasive screening test, when established, will greatly motivate patients to receive the test and thus bring the full benefits of early diagnosis. Eye tracking-based cognitive assessment (ETCA) is a method with scientific and medical foundation that is accessible to everyone, enabling patients to make the best of early diagnosis. The assessment uses data obtained from biological movements, namely of the eyes, toward images or videos, such as the percentage of fixation duration on the correct images, percentage of successful gaze detection, and gaze plot statistics and graphs. This innovative method enables the non-invasive, simple, objective, and quantitative determination of cognitive functions. Users simply look at the monitor screen and follow the instruction displayed to obtain their cognitive assessment.
We offer three core services: “Actaba” for detecting abandoned farmland, “Detaba” for estimating crop classification, and “Ninataba” for connecting farmland with people. By leveraging satellite data and land parcel information, we visualize farmland to promote effective use and sustainability. We also support environmental conservation and regenerative agriculture through soil analysis, calculation of GHG emissions and carbon removal (aligned with SBTi-FLAG), carbon credit projects, and the promotion of decarbonized agricultural materials.
A startup from Osaka University addressing the limitations of subjective pain assessment, which cannot capture pain accurately, by enabling objective pain evaluation through proprietary AI. By applying big data analytics and AI to EEG data and converting human pain into a 0–100 scale, we are developing and implementing a system that can measure pain in real time and continuously without directly questioning patients.
A tech-bio startup leveraging antibody big data and AI to tackle the challenges of drug discovery: identifying unresolved diseases and undiscovered target molecules. Breaking through the barriers of bio-data to pioneer new therapies.
